Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia

Glybochko P.V.

Alyaev Y.G. Yu G

Pshikhachev A.M.

Sorokin N.I.

Dymov A.M.

Department of Urology, I.M. Sechenov First MSMU, Research Institute of Uronephrology and Human Reproductive Health.

Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia

Текст визуальный электронный

Urologiia (Moscow, Russia : 1999)

№ 5 С. 92-96

2016

BPH

Holmium laser enucleation

benign prostatic hyperplasia

bladder cancer

bladder stones

bladder tumor

laser cystolithotripsy

transurethral resection

urothelial cancer

Статья

Aged M01.060.116.100

Пожилые M01.060.116.100

Aged, 80 and over M01.060.116.100.080

Пожилые 80-ти лет и старше M01.060.116.100.080

Humans B01.050.150.900.649.313.988.400.112.400.400

Человек B01.050.150.900.649.313.988.400.112.400.400

Kidney Calculi complications C12.050.351.968.419.600.500 C12.050.351.968.967.249.500 C12.050.351.968.967.500.503 C12.200.777.419.600.500 C12.200.777.967.249.500 C12.200.777.967.500.503 C12.950.419.600.500 C12.950.967.249.500 C12.950.967.500.503 C23.300.175.850.550

Kidney Calculi therapy C12.050.351.968.419.600.500 C12.050.351.968.967.249.500 C12.050.351.968.967.500.503 C12.200.777.419.600.500 C12.200.777.967.249.500 C12.200.777.967.500.503 C12.950.419.600.500 C12.950.967.249.500 C12.950.967.500.503 C23.300.175.850.550

Почечнокаменная болезнь осложнения C12.050.351.968.419.600.500 C12.050.351.968.967.249.500 C12.050.351.968.967.500.503 C12.200.777.419.600.500 C12.200.777.967.249.500 C12.200.777.967.500.503 C12.950.419.600.500 C12.950.967.249.500 C12.950.967.500.503 C23.300.175.850.550

Почечнокаменная болезнь терапия C12.050.351.968.419.600.500 C12.050.351.968.967.249.500 C12.050.351.968.967.500.503 C12.200.777.419.600.500 C12.200.777.967.249.500 C12.200.777.967.500.503 C12.950.419.600.500 C12.950.967.249.500 C12.950.967.500.503 C23.300.175.850.550

Lithotripsy, Laser E02.594.550 E02.600.500 E04.014.520.550 E04.943.500.500

Литотрипсия лазерная E02.594.550 E02.600.500 E04.014.520.550 E04.943.500.500

Male

Мужской

Middle Aged M01.060.116.630

Средний возраст M01.060.116.630

Neoplasm Recurrence, Local C04.697.655 C23.550.727.655

Новообразований рецидив местный C04.697.655 C23.550.727.655

Prostatic Hyperplasia complications C12.100.500.565.500 C12.200.294.565.500

Prostatic Hyperplasia surgery C12.100.500.565.500 C12.200.294.565.500

Предстательной железы гиперплазия осложнения C12.100.500.565.500 C12.200.294.565.500

Предстательной железы гиперплазия хирургия C12.100.500.565.500 C12.200.294.565.500

Urinary Bladder Neoplasms complications C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945

Urinary Bladder Neoplasms surgery C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945

Мочевого пузыря новообразования осложнения C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945

Мочевого пузыря новообразования хирургия C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945

Journal Article V02.600

Журнальная статья V02.600

To define treatment selection criteria for patients with bladder cancer combined with benign prostatic hyperplasia (BPH).